Alkermes Pathways Research Awards Grant

The Alkermes Pathways Research Awards program aims to foster research in neuroscience, specifically targeting schizophrenia and bipolar disorder. With grants up to $100,000, it supports early-career investigators exploring critical areas, including sleep and circadian disturbances related to these conditions. This initiative addresses the urgent need for innovative solutions in mental health research, empowering the next generation of scientists to make impactful contributions in understanding and treating these complex disorders.

About Pathways
With millions of people impacted by neurological disorders, more research is urgently needed to advance science in this area. The Alkermes Pathways Research Awards® program is designed to support the next generation of researchers who are working on the front lines to advance our understanding of diseases in the field of neuroscience.
The Alkermes Pathways Research Awards program provides opportunities for individual grants of up to $100,000 per research project for early-career investigators focused on research relating to schizophrenia or bipolar disorder, including sleep and circadian disturbances associated with these conditions.
Areas of Interest
Schizophrenia & Bipolar I DisorderNew in 2025: Sleep/circadian disturbances associated with Schizophrenia & Bipolar I Disorder (e.g., Excessive Daytime Sleepiness, Hypersomnolence.)